News | July 27, 2012

Elekta Grant to Support Pediatric Cancer Research in Spain

€32,000 bequest given to Madrid Hospital Foundation for research at Madrid’s Montepríncipe Hospital

July 27, 2012 — To support research exploring childhood cancers, Elekta has given a €32,000 ($40,000) grant to Madrid Hospital Foundation’s pediatric oncology program at the Madrid Montepríncipe Hospital's pediatric oncology and hematology unit. The donation was collected at a charity party held in conjunction with the 2012 Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona. The foundation’s pediatric oncology research programs focus on increasing the understanding of cancer in children, and on improving treatment methods and the patient’s quality of life.

“Because cancer occurs more often in adults than in children, most of today’s technological developments in radiation therapy focus on adult patients and their needs,” said Tomas Puusepp, president and CEO of Elekta. “To address this imbalance, we are pleased to support the efforts of worthy pediatric cancer research programs such as the foundation’s pediatric oncology program. Elekta’s own efforts are aimed at adapting radiation therapy treatments to children, such as developing more suitable immobilization devices and imaging strategies, and by studying how to adjust doses for pediatric patients. To that end, we recently created the Elekta Pediatric Research Group, whose mission is to identify, develop and adapt products to treat childhood cancer."

Elekta’s products are currently not approved for use on children.

For more information: www.elekta.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation